Single-cell developmental classification of B cell precursor acute lymphoblastic leukemia at diagnosis reveals predictors of relapse
暂无分享,去创建一个
Sean C. Bendall | Erin F. Simonds | R. Tibshirani | G. Nolan | K. Davis | N. Aghaeepour | Astraea Jager | W. Fantl | N. Samusik | Zinaida Good | A. Biondi | N. Lacayo | G. Gaipa | G. Fazio | L. White | J. Sarno | S. Bendall
[1] M. Greaves. Differentiation-linked leukemogenesis in lymphocytes. , 1986, Science.
[2] M. Borowitz,et al. Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1989, Blood.
[3] C. Pui,et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] R. Tibshirani. The lasso method for variable selection in the Cox model. , 1997, Statistics in medicine.
[5] C. Timmons,et al. Relapsed Childhood Acute Lymphoblastic Leukemia Presenting as an Isolated Breast Mass , 1999, Clinical pediatrics.
[6] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[7] R. Tibshirani,et al. Pre-validation and inference in microarrays , 2002, Statistical applications in genetics and molecular biology.
[8] Jonathan M Irish,et al. Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells , 2004, Cell.
[9] J. Rowley,et al. Mimicry of a constitutively active pre–B cell receptor in acute lymphoblastic leukemia cells , 2005, The Journal of experimental medicine.
[10] George Davidson,et al. Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study. , 2006, Blood.
[11] Tianxi Cai,et al. Evaluating Prediction Rules for t-Year Survivors With Censored Regression Models , 2007 .
[12] Christopher B. Miller,et al. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia , 2007, Nature.
[13] Christopher B. Miller,et al. BCR–ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros , 2008, Nature.
[14] Robert Tibshirani,et al. A study of pre-validation , 2008, 0807.4105.
[15] James R. Downing,et al. Genomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia , 2008, Science.
[16] S. Hunger,et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study. , 2008, Blood.
[17] Jonathan M Irish,et al. Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. , 2008, Cancer cell.
[18] T. Lebien,et al. B lymphocytes: how they develop and function. , 2008, Blood.
[19] Maria Grazia Valsecchi,et al. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] N. Heisterkamp,et al. Pre–B cell receptor–mediated cell cycle arrest in Philadelphia chromosome–positive acute lymphoblastic leukemia requires IKAROS function , 2009, The Journal of experimental medicine.
[21] Elizabeth A. Kruse,et al. MEK/ERK-Mediated Phosphorylation of Bim Is Required to Ensure Survival of T and B Lymphocytes during Mitogenic Stimulation , 2009, The Journal of Immunology.
[22] Martin Stanulla,et al. Treatment of childhood acute lymphoblastic leukemia. , 2009, Seminars in hematology.
[23] Trevor Hastie,et al. Regularization Paths for Generalized Linear Models via Coordinate Descent. , 2010, Journal of statistical software.
[24] J. V. van Dongen,et al. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. , 2010, Blood.
[25] Ash A. Alizadeh,et al. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression , 2010, Proceedings of the National Academy of Sciences.
[26] K. Anderson,et al. Genetic variegation of clonal architecture and propagating cells in leukaemia , 2011, Nature.
[27] M. Relling,et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. , 2011, Blood.
[28] M. Pencina,et al. On the C‐statistics for evaluating overall adequacy of risk prediction procedures with censored survival data , 2011, Statistics in medicine.
[29] Sean C. Bendall,et al. Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum , 2011, Science.
[30] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[31] Joshua F. McMichael,et al. The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.
[32] R. Arceci. Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2012 .
[33] Ken Chen,et al. Clonal architecture of secondary acute myeloid leukemia. , 2012, The New England journal of medicine.
[34] B. Druker,et al. Crosstalk between ROR1 and the Pre-B cell receptor promotes survival of t(1;19) acute lymphoblastic leukemia. , 2012, Cancer cell.
[35] Erin F. Simonds,et al. A platinum‐based covalent viability reagent for single‐cell mass cytometry , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[36] G. Nolan,et al. Decoupling of tumor-initiating activity from stable immunophenotype in HoxA9-Meis1-driven AML. , 2012, Cell stem cell.
[37] J. Lemerle,et al. A pediatric oncology group pilot study on childhood cancers at the Chantal Biya Foundation Yaounde, Cameroon: Report of 350 cases , 2012 .
[38] Sean C. Bendall,et al. Normalization of mass cytometry data with bead standards , 2013, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[39] D. Teachey,et al. Predicting relapse risk in childhood acute lymphoblastic leukaemia , 2013, British journal of haematology.
[40] Lu Tian,et al. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data , 2013, Statistics in medicine.
[41] Sean C. Bendall,et al. Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B Cell Development , 2014, Cell.
[42] Sean C. Bendall,et al. Conditional density-based analysis of T cell signaling in single-cell data , 2014, Science.
[43] M. Cleary,et al. The AML salad bowl. , 2014, Cancer cell.
[44] Malay Mandal,et al. Orchestrating B cell lymphopoiesis through interplay of IL-7 receptor and pre-B cell receptor signalling , 2013, Nature Reviews Immunology.
[45] Christopher A. Miller,et al. Functional heterogeneity of genetically defined subclones in acute myeloid leukemia. , 2014, Cancer cell.
[46] Sean C. Bendall,et al. Data-Driven Phenotypic Dissection of AML Reveals Progenitor-like Cells that Correlate with Prognosis , 2015, Cell.
[47] Eli R. Zunder,et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm , 2015, Nature Protocols.
[48] Eli R. Zunder,et al. A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. , 2015, Cell stem cell.
[49] Sean C. Bendall,et al. An interactive reference framework for modeling a dynamic immune system , 2015, Science.
[50] G. Nolan,et al. Automated Mapping of Phenotype Space with Single-Cell Data , 2016, Nature Methods.
[51] T. Graeber,et al. PTEN opposes negative selection and enables oncogenic transformation of pre-B cells , 2016, Nature Medicine.